CN Stock MarketDetailed Quotes

Kangmei Pharmaceutical (600518)

Watchlist
  • 1.56
  • +0.04+2.63%
Market Closed May 22 15:00 CST
21.57BMarket Cap-1560.00P/E (TTM)

Kangmei Pharmaceutical (600518) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Money funds
37.43%1.23B
26.82%1.24B
52.63%1.18B
13.54%902.63M
20.07%894.14M
-7.45%977.84M
-34.78%773.51M
-37.81%794.97M
-42.33%744.68M
-29.91%1.06B
Transactional financial assets
4.60%83.44K
8.25%87.65K
10.92%91.4K
10.01%80.05K
2.87%79.77K
-2.22%80.96K
-9.90%82.41K
-27.14%72.76K
-33.90%77.54K
-29.42%82.8K
Notes receivable and accounts receivable
-1.59%2.43B
-0.63%2.36B
8.86%2.52B
16.35%2.6B
12.28%2.47B
14.31%2.38B
22.18%2.31B
22.81%2.23B
11.48%2.2B
3.16%2.08B
-Notes receivable
15.48%62.4M
40.44%61.97M
-22.55%45.4M
-28.33%43.16M
-1.66%54.04M
-10.79%44.12M
10.54%58.61M
106.61%60.21M
-1.49%54.95M
-1.00%49.46M
-Accounts receivable
-1.98%2.37B
-1.40%2.3B
9.68%2.47B
17.59%2.56B
12.64%2.42B
14.92%2.33B
22.51%2.26B
21.45%2.17B
11.86%2.14B
3.27%2.03B
Other receivables (including interest and dividends)
-31.01%455.27M
-31.54%451.27M
-16.78%574.34M
-8.92%658.4M
-10.62%659.92M
-7.06%659.16M
-10.62%690.11M
-10.58%722.91M
-7.87%738.35M
-10.41%709.24M
-Other receivable
----
----
----
-8.92%658.4M
----
-7.06%659.16M
----
-10.58%722.91M
----
-10.41%709.24M
Advance payment
-1.33%128.08M
-18.78%142.6M
-24.97%87.68M
-26.40%96.54M
-17.25%129.81M
48.88%175.56M
-20.29%116.85M
-6.45%131.17M
-11.94%156.87M
-32.48%117.93M
Inventories
-5.32%2.38B
-10.91%2.24B
-15.01%2.45B
-15.46%2.44B
-10.46%2.51B
-5.04%2.51B
2.56%2.89B
6.44%2.89B
5.96%2.81B
-3.89%2.64B
Receivable financing
-21.79%35.14M
331.42%63.22M
110.15%55.24M
20.15%32.22M
265.50%44.94M
-10.08%14.65M
331.93%26.29M
19.06%26.82M
-72.65%12.29M
-32.71%16.3M
Other current assets
-19.70%147.23M
-16.02%156.46M
-21.40%159.62M
-13.26%170.6M
-7.21%183.34M
-0.51%186.3M
1.07%203.08M
3.77%196.68M
6.25%197.59M
55.64%187.25M
Total current assets
-1.31%6.8B
-3.60%6.65B
0.28%7.03B
-1.33%6.9B
0.57%6.89B
1.33%6.9B
-0.14%7.01B
0.34%6.99B
-3.76%6.86B
-7.78%6.81B
Non Current assets
Other equity investment
-5.95%1.05M
-6.02%1.04M
-9.57%1.05M
-3.58%1.08M
-1.75%1.11M
-3.52%1.11M
-15.81%1.16M
-19.73%1.12M
-18.67%1.13M
-17.19%1.15M
Investment real estate
-7.64%2.51B
-7.54%2.53B
-0.91%2.68B
-2.57%2.69B
-2.35%2.72B
-2.36%2.74B
0.12%2.71B
1.15%2.76B
1.29%2.78B
1.40%2.81B
Fixed assets
----
----
----
-6.95%3.14B
----
-6.92%3.21B
----
-7.24%3.37B
----
-7.64%3.45B
Constru in process
----
----
----
-0.45%171.87M
----
-16.74%175.32M
----
-17.79%172.64M
----
-2.29%210.56M
Productive biological assets
-5.52%354.52K
-5.46%358.7K
-44.29%366.84K
-45.41%371.03K
-46.46%375.22K
-47.45%379.41K
-11.39%658.45K
-11.08%679.62K
-10.78%700.79K
-10.50%721.96K
Intangible assets
1.03%409.02M
1.09%413.93M
-15.83%391.48M
-14.68%400.99M
-14.62%404.86M
-16.61%409.47M
-8.41%465.12M
-8.39%469.98M
-8.50%474.16M
-7.32%491.02M
Goodwill
-65.29%36.91M
-65.29%36.91M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
Long deferred expense
-7.19%47.41M
-9.20%49.99M
-19.23%49.44M
-18.24%50.26M
-20.73%51.08M
-17.17%55.05M
-15.54%61.21M
-21.28%61.48M
-20.79%64.44M
-23.34%66.47M
Deferred tax assets
-9.80%64.07M
-13.70%64.17M
-30.77%67.53M
-30.05%70.23M
-30.62%71.03M
-26.73%74.36M
-1.40%97.53M
1.84%100.4M
6.75%102.37M
4.66%101.48M
Usufruct assets
-18.48%86.53M
-29.30%82.05M
-48.93%93.03M
-47.24%102.12M
-49.80%106.16M
-46.65%116.06M
-18.51%182.15M
-15.51%193.57M
-4.34%211.46M
-6.51%217.54M
Other non current assets
-43.07%7.45M
54.87%16.77M
-33.96%22.21M
-40.34%16.93M
-44.12%13.09M
-50.56%10.83M
45.82%33.63M
48.38%28.38M
62.58%23.43M
49.44%21.9M
Total non current assets
-4.63%6.5B
-4.77%6.57B
-7.38%6.65B
-7.15%6.74B
-7.22%6.82B
-7.67%6.9B
-4.79%7.18B
-4.64%7.26B
-4.27%7.35B
-4.03%7.47B
Total assets
-2.96%13.31B
-4.19%13.22B
-3.60%13.68B
-4.29%13.64B
-3.46%13.71B
-3.38%13.8B
-2.55%14.19B
-2.26%14.26B
-4.02%14.21B
-5.86%14.28B
Liabilities
Current liabilities
Short term loan
147.24%81.59M
474.51%90.93M
21.61%14.84M
-14.16%20.1M
10.16%33M
-39.44%15.83M
-63.08%12.2M
99.81%23.41M
15.18%29.96M
2.02%26.14M
Notes payable and accounts payable
-2.00%2.46B
-7.50%2.35B
2.57%2.61B
-1.51%2.49B
4.03%2.51B
12.82%2.55B
14.66%2.54B
19.30%2.52B
6.93%2.41B
-11.98%2.26B
-Notes payable
122.86%167.52M
67.90%124.33M
97.68%74.69M
-40.89%53.18M
-16.38%75.17M
44.27%74.05M
-22.63%37.78M
145.31%89.96M
155.06%89.89M
68.85%51.33M
-Accounts payable
-5.86%2.29B
-9.76%2.23B
1.14%2.53B
-0.05%2.43B
4.83%2.43B
12.09%2.47B
15.50%2.51B
17.08%2.43B
4.58%2.32B
-12.95%2.21B
Contract liabilities
-20.08%112.07M
-22.83%91.7M
-15.03%146.87M
-10.40%136.11M
-2.50%140.22M
-25.69%118.82M
-11.47%172.84M
-23.61%151.91M
-26.51%143.82M
1.12%159.89M
Advance receipts
2.53%49.23M
-4.69%48.91M
50.70%60.22M
17.07%53.02M
18.39%48.01M
-12.51%51.32M
-39.89%39.96M
-31.21%45.29M
-35.94%40.55M
4.21%58.65M
Salaries payable
35.13%66.49M
6.40%70.85M
-6.12%58.81M
-4.03%56.96M
-27.45%49.21M
-12.94%66.58M
-62.01%62.64M
-65.32%59.35M
-61.04%67.83M
-57.80%76.48M
Taxs payable
2.39%424.92M
1.80%425.57M
1.99%418.71M
1.57%411.69M
1.99%414.99M
-26.83%418.04M
-57.40%410.54M
-57.89%405.33M
-58.69%406.88M
-42.79%571.3M
Other payable (including interest and dividends)
-10.36%1.19B
-11.49%1.18B
-19.11%1.25B
-6.01%1.29B
-5.82%1.33B
-4.71%1.34B
12.34%1.55B
0.29%1.37B
5.36%1.41B
5.54%1.4B
-Dividend payable
111.11%4.75M
122.22%5M
-10.00%2.25M
--2.25M
--2.25M
--2.25M
--2.5M
----
----
----
-Other payable
----
----
----
-6.18%1.29B
----
-4.87%1.34B
----
0.29%1.37B
----
5.54%1.4B
Non current liabilities due within one year
-8.50%23.55M
-16.94%23.54M
-26.74%25.3M
-24.76%27.3M
-34.69%25.73M
-30.37%28.35M
-15.56%34.54M
-9.34%36.28M
3.41%39.4M
4.08%40.71M
Other current liabilities
-23.52%974.34M
-25.61%974.94M
1,315.71%1.23B
1,402.01%1.27B
1,427.41%1.27B
-12.98%1.31B
-3.04%86.59M
-5.31%84.76M
-2.25%83.4M
1,605.06%1.51B
Total current liabilities
-7.57%5.38B
-10.65%5.27B
18.35%5.81B
22.36%5.75B
25.67%5.82B
-3.39%5.89B
-4.64%4.91B
-6.39%4.7B
-10.23%4.63B
12.10%6.1B
Current liabilities
Long term account payable
----
----
----
----
----
----
----
-4.27%805.12M
----
----
Estimate liabilities
-8.92%16.21M
-8.68%16.25M
-97.25%17.09M
-97.86%17.65M
-97.86%17.79M
-92.63%17.79M
-30.50%621.5M
-15.14%823.83M
-15.04%832.44M
-75.39%241.31M
Deferred tax liabilities
-22.35%19.19M
-28.13%19.3M
-51.77%21.15M
-48.37%23.97M
-51.22%24.71M
-48.05%26.85M
-21.25%43.85M
-18.62%46.43M
-7.88%50.66M
-6.93%51.68M
Long term deferred income
-5.74%516.2M
-5.90%523.01M
-10.42%530.15M
-10.77%538.41M
-10.36%547.64M
-10.17%555.78M
-6.00%591.85M
-5.34%603.42M
-5.43%610.9M
-5.40%618.68M
Lease liabilities
-22.00%68.57M
-26.40%69.89M
-53.64%78.45M
-52.26%84.24M
-52.89%87.91M
-49.54%94.95M
-13.61%169.19M
-11.63%176.46M
-1.59%186.62M
-5.51%188.16M
Total non current liabilities
-8.54%620.16M
-9.62%628.45M
-70.70%646.84M
-72.94%664.28M
-72.73%678.05M
-36.78%695.37M
-14.49%2.21B
-9.27%2.46B
-8.36%2.49B
-59.91%1.1B
Total liabilities
-7.67%6B
-10.54%5.89B
-9.27%6.46B
-10.33%6.42B
-8.71%6.5B
-8.49%6.59B
-7.93%7.12B
-7.40%7.16B
-9.59%7.12B
-12.03%7.2B
Shareholders equity
Paid-in capital
-0.25%13.83B
-0.25%13.83B
-0.25%13.83B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
Capital reserve funds
-1.64%18.47B
-1.64%18.47B
-1.64%18.47B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
Surplus reserve funds
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
Retained profit
-0.06%-25.9B
0.04%-25.88B
0.06%-25.88B
0.04%-25.88B
0.04%-25.88B
0.03%-25.89B
0.98%-25.9B
0.93%-25.89B
0.62%-25.89B
0.39%-25.9B
Less:Treasury stock
-40.38%659.92M
-40.38%659.92M
-38.18%763.92M
-9.55%1.11B
-9.64%1.11B
-9.64%1.11B
1.17%1.24B
0.45%1.22B
0.24%1.23B
0.26%1.23B
Other composite income
-36.59%-361.05K
-30.61%-345.25K
-53.04%-333.92K
-16.94%-294.66K
-116.98%-264.34K
-164.20%-264.34K
-278.31%-218.19K
-274.61%-251.97K
-190.09%-121.82K
-173.69%-100.05K
Specific reserves
152.54%3.66M
147.77%3.57M
11.54%1.57M
9.52%1.5M
20.13%1.45M
12.75%1.44M
22.05%1.41M
16.33%1.37M
-6.80%1.21M
-1.35%1.28M
Shareholders equity without minority interests
1.26%7.27B
1.61%7.29B
2.06%7.19B
1.79%7.19B
1.81%7.18B
1.80%7.17B
3.55%7.04B
3.49%7.06B
2.28%7.05B
1.43%7.05B
Minority interests
2.79%35.98M
2.48%35.4M
11.72%37.91M
1.85%36.41M
1.97%35.01M
5.03%34.55M
1.89%33.93M
9.58%35.75M
5.72%34.33M
-7.16%32.89M
Total shareholder equity
1.27%7.31B
1.62%7.33B
2.10%7.22B
1.79%7.23B
1.81%7.22B
1.81%7.21B
3.54%7.08B
3.52%7.1B
2.29%7.09B
1.38%7.08B
Total liabilityies and equity
-2.96%13.31B
-4.19%13.22B
-3.60%13.68B
-4.29%13.64B
-3.46%13.71B
-3.38%13.8B
-2.55%14.19B
-2.26%14.26B
-4.02%14.21B
-5.86%14.28B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
Tianzhi International Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Money funds 37.43%1.23B26.82%1.24B52.63%1.18B13.54%902.63M20.07%894.14M-7.45%977.84M-34.78%773.51M-37.81%794.97M-42.33%744.68M-29.91%1.06B
Transactional financial assets 4.60%83.44K8.25%87.65K10.92%91.4K10.01%80.05K2.87%79.77K-2.22%80.96K-9.90%82.41K-27.14%72.76K-33.90%77.54K-29.42%82.8K
Notes receivable and accounts receivable -1.59%2.43B-0.63%2.36B8.86%2.52B16.35%2.6B12.28%2.47B14.31%2.38B22.18%2.31B22.81%2.23B11.48%2.2B3.16%2.08B
-Notes receivable 15.48%62.4M40.44%61.97M-22.55%45.4M-28.33%43.16M-1.66%54.04M-10.79%44.12M10.54%58.61M106.61%60.21M-1.49%54.95M-1.00%49.46M
-Accounts receivable -1.98%2.37B-1.40%2.3B9.68%2.47B17.59%2.56B12.64%2.42B14.92%2.33B22.51%2.26B21.45%2.17B11.86%2.14B3.27%2.03B
Other receivables (including interest and dividends) -31.01%455.27M-31.54%451.27M-16.78%574.34M-8.92%658.4M-10.62%659.92M-7.06%659.16M-10.62%690.11M-10.58%722.91M-7.87%738.35M-10.41%709.24M
-Other receivable -------------8.92%658.4M-----7.06%659.16M-----10.58%722.91M-----10.41%709.24M
Advance payment -1.33%128.08M-18.78%142.6M-24.97%87.68M-26.40%96.54M-17.25%129.81M48.88%175.56M-20.29%116.85M-6.45%131.17M-11.94%156.87M-32.48%117.93M
Inventories -5.32%2.38B-10.91%2.24B-15.01%2.45B-15.46%2.44B-10.46%2.51B-5.04%2.51B2.56%2.89B6.44%2.89B5.96%2.81B-3.89%2.64B
Receivable financing -21.79%35.14M331.42%63.22M110.15%55.24M20.15%32.22M265.50%44.94M-10.08%14.65M331.93%26.29M19.06%26.82M-72.65%12.29M-32.71%16.3M
Other current assets -19.70%147.23M-16.02%156.46M-21.40%159.62M-13.26%170.6M-7.21%183.34M-0.51%186.3M1.07%203.08M3.77%196.68M6.25%197.59M55.64%187.25M
Total current assets -1.31%6.8B-3.60%6.65B0.28%7.03B-1.33%6.9B0.57%6.89B1.33%6.9B-0.14%7.01B0.34%6.99B-3.76%6.86B-7.78%6.81B
Non Current assets
Other equity investment -5.95%1.05M-6.02%1.04M-9.57%1.05M-3.58%1.08M-1.75%1.11M-3.52%1.11M-15.81%1.16M-19.73%1.12M-18.67%1.13M-17.19%1.15M
Investment real estate -7.64%2.51B-7.54%2.53B-0.91%2.68B-2.57%2.69B-2.35%2.72B-2.36%2.74B0.12%2.71B1.15%2.76B1.29%2.78B1.40%2.81B
Fixed assets -------------6.95%3.14B-----6.92%3.21B-----7.24%3.37B-----7.64%3.45B
Constru in process -------------0.45%171.87M-----16.74%175.32M-----17.79%172.64M-----2.29%210.56M
Productive biological assets -5.52%354.52K-5.46%358.7K-44.29%366.84K-45.41%371.03K-46.46%375.22K-47.45%379.41K-11.39%658.45K-11.08%679.62K-10.78%700.79K-10.50%721.96K
Intangible assets 1.03%409.02M1.09%413.93M-15.83%391.48M-14.68%400.99M-14.62%404.86M-16.61%409.47M-8.41%465.12M-8.39%469.98M-8.50%474.16M-7.32%491.02M
Goodwill -65.29%36.91M-65.29%36.91M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M
Long deferred expense -7.19%47.41M-9.20%49.99M-19.23%49.44M-18.24%50.26M-20.73%51.08M-17.17%55.05M-15.54%61.21M-21.28%61.48M-20.79%64.44M-23.34%66.47M
Deferred tax assets -9.80%64.07M-13.70%64.17M-30.77%67.53M-30.05%70.23M-30.62%71.03M-26.73%74.36M-1.40%97.53M1.84%100.4M6.75%102.37M4.66%101.48M
Usufruct assets -18.48%86.53M-29.30%82.05M-48.93%93.03M-47.24%102.12M-49.80%106.16M-46.65%116.06M-18.51%182.15M-15.51%193.57M-4.34%211.46M-6.51%217.54M
Other non current assets -43.07%7.45M54.87%16.77M-33.96%22.21M-40.34%16.93M-44.12%13.09M-50.56%10.83M45.82%33.63M48.38%28.38M62.58%23.43M49.44%21.9M
Total non current assets -4.63%6.5B-4.77%6.57B-7.38%6.65B-7.15%6.74B-7.22%6.82B-7.67%6.9B-4.79%7.18B-4.64%7.26B-4.27%7.35B-4.03%7.47B
Total assets -2.96%13.31B-4.19%13.22B-3.60%13.68B-4.29%13.64B-3.46%13.71B-3.38%13.8B-2.55%14.19B-2.26%14.26B-4.02%14.21B-5.86%14.28B
Liabilities
Current liabilities
Short term loan 147.24%81.59M474.51%90.93M21.61%14.84M-14.16%20.1M10.16%33M-39.44%15.83M-63.08%12.2M99.81%23.41M15.18%29.96M2.02%26.14M
Notes payable and accounts payable -2.00%2.46B-7.50%2.35B2.57%2.61B-1.51%2.49B4.03%2.51B12.82%2.55B14.66%2.54B19.30%2.52B6.93%2.41B-11.98%2.26B
-Notes payable 122.86%167.52M67.90%124.33M97.68%74.69M-40.89%53.18M-16.38%75.17M44.27%74.05M-22.63%37.78M145.31%89.96M155.06%89.89M68.85%51.33M
-Accounts payable -5.86%2.29B-9.76%2.23B1.14%2.53B-0.05%2.43B4.83%2.43B12.09%2.47B15.50%2.51B17.08%2.43B4.58%2.32B-12.95%2.21B
Contract liabilities -20.08%112.07M-22.83%91.7M-15.03%146.87M-10.40%136.11M-2.50%140.22M-25.69%118.82M-11.47%172.84M-23.61%151.91M-26.51%143.82M1.12%159.89M
Advance receipts 2.53%49.23M-4.69%48.91M50.70%60.22M17.07%53.02M18.39%48.01M-12.51%51.32M-39.89%39.96M-31.21%45.29M-35.94%40.55M4.21%58.65M
Salaries payable 35.13%66.49M6.40%70.85M-6.12%58.81M-4.03%56.96M-27.45%49.21M-12.94%66.58M-62.01%62.64M-65.32%59.35M-61.04%67.83M-57.80%76.48M
Taxs payable 2.39%424.92M1.80%425.57M1.99%418.71M1.57%411.69M1.99%414.99M-26.83%418.04M-57.40%410.54M-57.89%405.33M-58.69%406.88M-42.79%571.3M
Other payable (including interest and dividends) -10.36%1.19B-11.49%1.18B-19.11%1.25B-6.01%1.29B-5.82%1.33B-4.71%1.34B12.34%1.55B0.29%1.37B5.36%1.41B5.54%1.4B
-Dividend payable 111.11%4.75M122.22%5M-10.00%2.25M--2.25M--2.25M--2.25M--2.5M------------
-Other payable -------------6.18%1.29B-----4.87%1.34B----0.29%1.37B----5.54%1.4B
Non current liabilities due within one year -8.50%23.55M-16.94%23.54M-26.74%25.3M-24.76%27.3M-34.69%25.73M-30.37%28.35M-15.56%34.54M-9.34%36.28M3.41%39.4M4.08%40.71M
Other current liabilities -23.52%974.34M-25.61%974.94M1,315.71%1.23B1,402.01%1.27B1,427.41%1.27B-12.98%1.31B-3.04%86.59M-5.31%84.76M-2.25%83.4M1,605.06%1.51B
Total current liabilities -7.57%5.38B-10.65%5.27B18.35%5.81B22.36%5.75B25.67%5.82B-3.39%5.89B-4.64%4.91B-6.39%4.7B-10.23%4.63B12.10%6.1B
Current liabilities
Long term account payable -----------------------------4.27%805.12M--------
Estimate liabilities -8.92%16.21M-8.68%16.25M-97.25%17.09M-97.86%17.65M-97.86%17.79M-92.63%17.79M-30.50%621.5M-15.14%823.83M-15.04%832.44M-75.39%241.31M
Deferred tax liabilities -22.35%19.19M-28.13%19.3M-51.77%21.15M-48.37%23.97M-51.22%24.71M-48.05%26.85M-21.25%43.85M-18.62%46.43M-7.88%50.66M-6.93%51.68M
Long term deferred income -5.74%516.2M-5.90%523.01M-10.42%530.15M-10.77%538.41M-10.36%547.64M-10.17%555.78M-6.00%591.85M-5.34%603.42M-5.43%610.9M-5.40%618.68M
Lease liabilities -22.00%68.57M-26.40%69.89M-53.64%78.45M-52.26%84.24M-52.89%87.91M-49.54%94.95M-13.61%169.19M-11.63%176.46M-1.59%186.62M-5.51%188.16M
Total non current liabilities -8.54%620.16M-9.62%628.45M-70.70%646.84M-72.94%664.28M-72.73%678.05M-36.78%695.37M-14.49%2.21B-9.27%2.46B-8.36%2.49B-59.91%1.1B
Total liabilities -7.67%6B-10.54%5.89B-9.27%6.46B-10.33%6.42B-8.71%6.5B-8.49%6.59B-7.93%7.12B-7.40%7.16B-9.59%7.12B-12.03%7.2B
Shareholders equity
Paid-in capital -0.25%13.83B-0.25%13.83B-0.25%13.83B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B
Capital reserve funds -1.64%18.47B-1.64%18.47B-1.64%18.47B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B
Surplus reserve funds 0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B
Retained profit -0.06%-25.9B0.04%-25.88B0.06%-25.88B0.04%-25.88B0.04%-25.88B0.03%-25.89B0.98%-25.9B0.93%-25.89B0.62%-25.89B0.39%-25.9B
Less:Treasury stock -40.38%659.92M-40.38%659.92M-38.18%763.92M-9.55%1.11B-9.64%1.11B-9.64%1.11B1.17%1.24B0.45%1.22B0.24%1.23B0.26%1.23B
Other composite income -36.59%-361.05K-30.61%-345.25K-53.04%-333.92K-16.94%-294.66K-116.98%-264.34K-164.20%-264.34K-278.31%-218.19K-274.61%-251.97K-190.09%-121.82K-173.69%-100.05K
Specific reserves 152.54%3.66M147.77%3.57M11.54%1.57M9.52%1.5M20.13%1.45M12.75%1.44M22.05%1.41M16.33%1.37M-6.80%1.21M-1.35%1.28M
Shareholders equity without minority interests 1.26%7.27B1.61%7.29B2.06%7.19B1.79%7.19B1.81%7.18B1.80%7.17B3.55%7.04B3.49%7.06B2.28%7.05B1.43%7.05B
Minority interests 2.79%35.98M2.48%35.4M11.72%37.91M1.85%36.41M1.97%35.01M5.03%34.55M1.89%33.93M9.58%35.75M5.72%34.33M-7.16%32.89M
Total shareholder equity 1.27%7.31B1.62%7.33B2.10%7.22B1.79%7.23B1.81%7.22B1.81%7.21B3.54%7.08B3.52%7.1B2.29%7.09B1.38%7.08B
Total liabilityies and equity -2.96%13.31B-4.19%13.22B-3.60%13.68B-4.29%13.64B-3.46%13.71B-3.38%13.8B-2.55%14.19B-2.26%14.26B-4.02%14.21B-5.86%14.28B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership)------Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership)------Tianzhi International Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More